160 related articles for article (PubMed ID: 29237039)
21. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline.
Chou R; Fanciullo GJ; Fine PG; Miaskowski C; Passik SD; Portenoy RK
J Pain; 2009 Feb; 10(2):131-46. PubMed ID: 19187890
[TBL] [Abstract][Full Text] [Related]
22. Patient vs provider reports of aberrant medication-taking behavior among opioid-treated patients with chronic pain who report misusing opioid medication.
Nikulina V; Guarino H; Acosta MC; Marsch LA; Syckes C; Moore SK; Portenoy RK; Cruciani RA; Turk DC; Rosenblum A
Pain; 2016 Aug; 157(8):1791-1798. PubMed ID: 27082008
[TBL] [Abstract][Full Text] [Related]
23. Predicting Risk for Opioid Misuse in Chronic Pain with a Single-Item Measure of Catastrophic Thinking.
Lutz J; Gross R; Long D; Cox S
J Am Board Fam Med; 2017; 30(6):828-831. PubMed ID: 29180559
[TBL] [Abstract][Full Text] [Related]
24. Validation of a screener and opioid assessment measure for patients with chronic pain.
Butler SF; Budman SH; Fernandez K; Jamison RN
Pain; 2004 Nov; 112(1-2):65-75. PubMed ID: 15494186
[TBL] [Abstract][Full Text] [Related]
25. Aberrant drug-related behavior observed during a 12-week open-label extension period of a study involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet or traditional short-acting opioid for breakthrough pain.
Passik SD; Narayana A; Yang R
Pain Med; 2014 Aug; 15(8):1365-72. PubMed ID: 24666664
[TBL] [Abstract][Full Text] [Related]
26. Translation, Cultural Adaptation and Validation of the Current Opioid Misuse Measure for European Portuguese.
Mendes-Morais D; Jantarada C; Guimarães-Pereira L
Acta Med Port; 2020 Apr; 33(4):261-268. PubMed ID: 32238240
[TBL] [Abstract][Full Text] [Related]
27. Dispositional mindfulness and prescription opioid misuse among chronic pain patients: Craving and attention to positive information as mediating mechanisms.
Priddy SE; Hanley AW; Riquino MR; Platt KA; Baker AK; Garland EL
Drug Alcohol Depend; 2018 Jul; 188():86-93. PubMed ID: 29754031
[TBL] [Abstract][Full Text] [Related]
28. Validation of a new risk assessment tool: the Brief Risk Questionnaire.
Jones T; Lookatch S; Moore T
J Opioid Manag; 2015; 11(2):171-83. PubMed ID: 25901482
[TBL] [Abstract][Full Text] [Related]
29. Screening for current opioid misuse and associated risk factors among patients with chronic nonalcoholic pancreatitis pain.
Barth KS; Balliet W; Pelic CM; Madan A; Malcolm R; Adams D; Morgan K; Owczarski S; Borckardt JJ
Pain Med; 2014 Aug; 15(8):1359-64. PubMed ID: 24716629
[TBL] [Abstract][Full Text] [Related]
30. Development of Short-Form Versions of the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R): A Proof-of-Principle Study.
Finkelman MD; Smits N; Kulich RJ; Zacharoff KL; Magnuson BE; Chang H; Dong J; Butler SF
Pain Med; 2017 Jul; 18(7):1292-1302. PubMed ID: 27605589
[TBL] [Abstract][Full Text] [Related]
31. Systematic review to determine which validated measurement tools can be used to assess risk of problematic analgesic use in patients with chronic pain.
Lawrence R; Mogford D; Colvin L
Br J Anaesth; 2017 Dec; 119(6):1092-1109. PubMed ID: 28981581
[TBL] [Abstract][Full Text] [Related]
32. The content validation of the Self-Reported Misuse, Abuse and Diversion of Prescription Opioids (SR-MAD) instrument for use in patients with acute or chronic pain.
Setnik B; Roland CL; Barsdorf AI; Brooks A; Coyne KS
Curr Med Res Opin; 2017 Jun; 33(6):1067-1076. PubMed ID: 28277862
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the current opioid misuse measure among substance use disorder treatment patients.
Ashrafioun L; Bohnert AS; Jannausch M; Ilgen MA
J Subst Abuse Treat; 2015 Aug; 55():15-20. PubMed ID: 25800105
[TBL] [Abstract][Full Text] [Related]
34. Spanish Validation of the COMM Scale to Assess the Misuse of Prescription Opioids in Patients with Chronic Noncancer Pain.
Reyes-Pérez Á; López-Martínez AE; Esteve R; Ramírez-Maestre C
Int J Ment Health Addict; 2022 Mar; ():1-15. PubMed ID: 35342377
[TBL] [Abstract][Full Text] [Related]
35. Anhedonia in chronic pain and prescription opioid misuse.
Garland EL; Trøstheim M; Eikemo M; Ernst G; Leknes S
Psychol Med; 2020 Sep; 50(12):1977-1988. PubMed ID: 31422776
[TBL] [Abstract][Full Text] [Related]
36. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse (Part 2).
Kaye AD; Jones MR; Kaye AM; Ripoll JG; Jones DE; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
Pain Physician; 2017 Feb; 20(2S):S111-S133. PubMed ID: 28226334
[TBL] [Abstract][Full Text] [Related]
37. A comparison of various risk screening methods in predicting discharge from opioid treatment.
Jones T; Moore T; Levy JL; Daffron S; Browder JH; Allen L; Passik SD
Clin J Pain; 2012 Feb; 28(2):93-100. PubMed ID: 21750461
[TBL] [Abstract][Full Text] [Related]
38. Chronic Pain and Risk Factors for Opioid Misuse in a Palliative Care Clinic.
Childers JW; King LA; Arnold RM
Am J Hosp Palliat Care; 2015 Sep; 32(6):654-9. PubMed ID: 24744398
[TBL] [Abstract][Full Text] [Related]
39. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.
Kaye AD; Jones MR; Kaye AM; Ripoll JG; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
Pain Physician; 2017 Feb; 20(2S):S93-S109. PubMed ID: 28226333
[TBL] [Abstract][Full Text] [Related]
40. A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management.
Moore TM; Jones T; Browder JH; Daffron S; Passik SD
Pain Med; 2009 Nov; 10(8):1426-33. PubMed ID: 20021601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
